FRANKFURT--The following is a summary of analysts' forecasts for
Novartis AG (NVS) third-quarter results, based on a poll of nine
analysts conducted by Dow Jones Newswires (figures in million
dollars, EPS in dollar, target price in francs, according to IFRS).
Earnings figures are scheduled to be released October 28.
===
Net sales:
3rd Quarter -Total -Pharma -Diovan -Gleevec -Lucentis
AVERAGE 14,551 7,800 443 1,120 615
Prev. Year 14,196 7,893 835 1,133 581
+/- in % +2.5 -1.2 -47 -1.2 +5.8
MEDIAN 14,538 7,803 430 1,125 615
Maximum 14,829 7,883 565 1,163 635
Minimum 14,344 7,686 376 1,060 599
Amount 8 8 6 6 7
Bernstein 14,369 7,809 424 1,163 624
Cowen and Company 14,525 7,780 435 1,125 625
Credit Suisse 14,627 -- -- -- --
Deutsche Bank 14,646 7,883 565 1,124 604
J.P. Morgan 14,551 7,877 -- -- --
Jefferies -- 7,796 446 1,060 615
Kepler Cheuvreux 14,829 7,877 413 1,130 635
Morgan Stanley 14,516 7,686 376 1,115 600
UBS 14,344 7,694 -- -- 599
Core Core
Operating Net Core
3rd Quarter income income EPS
AVERAGE 3,742 3,243 1.32
Prev. Year 3,555 3,062 1.24
+/- in % +5.3 +5.9 +6.7
MEDIAN 3,737 3,260 1.33
Maximum 3,958 3,369 1.37
Minimum 3,602 3,094 1.26
Amount 9 6 9
Bernstein 3,626 3,094 1.26
Cowen and Company 3,790 3,259 1.34
Credit Suisse 3,602 -- 1.28
Deutsche Bank 3,958 3,369 1.37
J.P. Morgan 3,746 -- 1.34
Jefferies 3,778 3,262 1.33
Kepler Cheuvreux 3,722 3,261 1.34
Morgan Stanley 3,737 -- 1.33
UBS 3,721 3,215 1.32
Target price Rating
AVERAGE 91.67 positive 3
Prev. Quarter 84.17 neutral 2
+/- in % +8.9 negative 1
MEDIAN 91.00
Maximum 100.00
Minimum 84.00
Amount 6
Deutsche Bank 85.00 Hold
J.P. Morgan 100.00 Overweight
Jefferies 99.00 Buy
Kepler Cheuvreux 87.00 Hold
Morgan Stanley 84.00 Underweight
UBS 95.00 Buy
===
Year-earlier figures are as restated by the company.
DJG/err
Subscribe to WSJ: http://online.wsj.com?mod=djnwires